Methylated DNA markers for monitoring palliative chemotherapy response in advanced colorectal cancer.

Mojun Zhu,Douglas W. Mahoney,Kelli N. Burger,Patrick H. Foote,Karen A Doering,William R. Taylor,Sara S Then,Hao Xie,Hatim T. Allawi,Michael W. Kaiser,Graham P. Lidgard,Joleen M Hubbard,John B. Kisiel

Methylated DNA markers for monitoring palliative chemotherapy response in advanced colorectal cancer.

2021

Mojun Zhu
Douglas W. Mahoney
Kelli N. Burger
Patrick H. Foote
Karen A Doering
William R. Taylor
Sara S Then
Hao Xie
Hatim T. Allawi
Michael W. Kaiser
Graham P. Lidgard
Joleen M Hubbard
John B. Kisiel

e15511Background: Aberrantly methylated DNA marker (MDM) candidates are strongly associated with primary colorectal cancer (CRC) before treatment and detect CRC recurrence with high sensitivity whe...

Keywords:

palliative chemotherapy
Oncology
Medicine
Colorectal cancer
Genetic marker
advanced colorectal cancer
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations